AR051595A1 - Composiciones farmaceuticas a base de nk2 antagonista para uso pediatrico - Google Patents
Composiciones farmaceuticas a base de nk2 antagonista para uso pediatricoInfo
- Publication number
- AR051595A1 AR051595A1 ARP050104429A ARP050104429A AR051595A1 AR 051595 A1 AR051595 A1 AR 051595A1 AR P050104429 A ARP050104429 A AR P050104429A AR P050104429 A ARP050104429 A AR P050104429A AR 051595 A1 AR051595 A1 AR 051595A1
- Authority
- AR
- Argentina
- Prior art keywords
- piperidin
- dichlorophenyl
- cycle
- ylmethyl
- phenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describen composiciones farmacéuticas que contienen NK2 antagonistas utiles para el tratamiento de colicos infantiles. Reivindicacion 15: Composiciones farmacéuticas segun las reivindicaciones 13 y 14 caracterizado porque dicho antagonista de las taquiquininas es un antagonista NK-2 o un antagonista mixto NK-2/NK-3, NK-1/NK-2 o NK-1/NK-2/NK-3. Reivindicacion 16: Composiciones farmacéuticas segun lo reivindicado en la cláusula 15 caracterizado porque dichos antagonistas son seleccionados en el grupo constituido por: Nalfa[Nalfa(benzo[b]tiofenil-2-ilcarbonil)-1-aminociclopentan-1-carbonil]-D-fenilalanina-N-[3(morfolin-4-il)propil]amida; Amida [1-(2-fenil-1R-{[1-(tetrahidropiran-4-ilmetil)-piperidin-4-ilmetil]-carbamoil}- etilcarbamoil)-ciclopentido] del ácido 6-bromo-benzo[b]tiofen-2-carboxílico, sal de TFA; Amida de [1-(2-fenil-1R-{[1-(tetrahidropiran-4-ilmetil)-piperidin-4-ilmetil]-carbamoil}-etilcarbamoil)-ciclopentil] del ácido 6-bromo-naftalen-2-carboxílico; Amida [1-(2-fenil-1R-{[1-(tetrahidropiran-4-ilmetil)-piperidin-4-ilmetil]-carbamoil}-etilcarbamoil)-ciclopentil] del ácido 5-yodo-benzofuran-2-carboxílico; Amida [1-(2-fenil-1R-{[1-(tetrahidropiran-4-ilmetil)-piperidin-4-ilmetil]-carbamoil}- etilcarbamoil)-ciclopentil] del ácido 6-metil-benzo[b]tiofen-2-carboxílico; ciclo ((Asn (beta-D-2-deoxi-2 acetamido-Glc)-Asp-Trp-Phe-Dap-Leu) ciclo (2beta-5beta)), (nepadutant); ciclo ((Asn (beta-D-galactopiranosil)-Asp-Trp-Phe-Dap-Leu) ciclo (2beta- 5beta)); ciclo ((Asn (4-O-(alfa-D-Glc)-beta-D-Glc)Asp-Trp-Phe-Dap-Leu) ciclo (2beta-5beta)); ciclo (Dap(lactobionil-Asp-Trp-Phe-Dap-Leu) ciclo (2beta-5beta)); ciclo {-Suc[1-(R)-2(4-morfolin-4-il piperidin-1-il)acetilamino]-Trp-Phe-[(R)-NH-CH(CH2- C6H5)-CH2NH]-}; ciclo {-Suc[1-(R)-2(4-morfolin-4-piperidin-1-il acetil)amino]-Trp(5-F)-Phe-[(R)-NH-CH(CH2-C6H5)-CH2NH]-}; (S)-N-[4-(4-Acetamido-4-fenilpiperidin-1-il)-2-(3,4-diclorofenil)-butil]-N-metilbenzamida (saredutant); 4-[1-[2-[1- (Ciclopropilmetil)-3(S)-(3,4-diclorofenil)-6-oxo-piperidin-3-il]etil]azetidin-3-il]piperazine-sulfonamida; (+)-(R)-N-[1-[2[4-Benzoil-2-(3,4-dilfluorofenil)morfolin-2-il]etil]-4-fenilpiperidin-4-il]-N',N'-dimetilurea; 5(S)-(3,4-Diclorofenil)-1-(4,4- difluorociclohexilmetil)-5-[2-[3-(4-fluoropiperidin-1-il)azetidin-1-il]etl]piperidin-2-ona; S-oxido de N-[2-(3-4-Diclorofenil)-4-[espiro[benzo[b]tiofen-1(3H),4'-piperidin]-1'-il]butil]-N-metilbenzamida; Fumarato de N-[2-(3,4-Diclorofenil)-4-(3-oxo- 1,2,3,4-tetrahidrospiro[isoquinolin-1,4'-piperidin]-1'-il)butil]-4-fluoro-N-metilbenzamida; 2-Fenil-3-[4-(1-piperidinil)piperidin-1-ilmetil]-N-[1(S),2,2-trimetilpropil]quinolin-4-carboxamida; 2-Bencil-4-(2-benciloxietil)-1-(N-tert-butilcarbamoil-L- glutaminil-L-triptofil)semicarbazida; 5-(3,4-Diclorofenil)-4(R)-[N-metil-3,5-bis(trifluorometil)-benzamido]-N-[2-oxoperhidroazepin-3-(R)-il]-2(E)-pentenamida; Citrato de 3-Ciano-N-[2(S)-(3,4-diclorofenil)-4-[4-[4-metoxi-2-[[S(S)]- metilsulfinil]fenil]piperidin-1-il]butil]-N-metilnaftalen-1-carboxamida; Fumarato de 3-ciano-N-[2(S)-(3,4-diclorofenil)-4-[4-[2-[(S)-metilsulfinil]fenil]piperidin-1-il]butil]-N-metilnaftalen-1-carboxamida; N-[2-(3,4-Diclorofenil)-4-[3-oxo-1,2,3,4- tetrahidrospiro[isoquinolin-1,4'-piperidin]-1'-il]butil]-3,4,5-trimetoxi-N-metilbenzamida; Hidrocloruro de 1'-[2-[2(R)-(3,4-Diclorofenil)-4-(3,4,5-trimetoxibenzoil)morfonil-2-il]etil]espiro[benzo[c]tiofen-1(3H)-4'-piperidina]2(S)-oxido; N-[3(R)-(3,4- Diclorofenil)-5-[4-[3(R)-(N-metilcarbamoilmetil)-2-oxopiperidin-1-il]piperidin-1-il]-2(Z)-(metoxiimino)pentil]-N-metil-3,5-diclorobenzamida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000221A ITFI20040221A1 (it) | 2004-10-27 | 2004-10-27 | Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico |
Publications (1)
Publication Number | Publication Date |
---|---|
AR051595A1 true AR051595A1 (es) | 2007-01-24 |
Family
ID=35613882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050104429A AR051595A1 (es) | 2004-10-27 | 2005-10-24 | Composiciones farmaceuticas a base de nk2 antagonista para uso pediatrico |
Country Status (26)
Country | Link |
---|---|
US (2) | US7727955B2 (es) |
EP (1) | EP1809267B1 (es) |
JP (1) | JP2008517977A (es) |
CN (1) | CN101052386A (es) |
AR (1) | AR051595A1 (es) |
AT (1) | ATE422881T1 (es) |
AU (1) | AU2005298629B2 (es) |
CA (1) | CA2584481C (es) |
CY (1) | CY1109803T1 (es) |
DE (1) | DE602005012857D1 (es) |
DK (1) | DK1809267T3 (es) |
EA (1) | EA012264B1 (es) |
ES (1) | ES2325413T3 (es) |
HK (1) | HK1109335A1 (es) |
HR (1) | HRP20090225T1 (es) |
IT (1) | ITFI20040221A1 (es) |
MX (1) | MX2007004461A (es) |
NO (1) | NO338586B1 (es) |
NZ (1) | NZ555380A (es) |
PL (1) | PL1809267T3 (es) |
PT (1) | PT1809267E (es) |
RS (1) | RS50780B (es) |
SI (1) | SI1809267T1 (es) |
UA (1) | UA91988C2 (es) |
WO (1) | WO2006045820A1 (es) |
ZA (1) | ZA200703909B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0614970D0 (en) * | 2006-07-27 | 2006-09-06 | R & D Sosei Ltd | Compounds For Use In Therapy |
IT1394304B1 (it) * | 2009-05-21 | 2012-06-06 | Malesci Sas | Processo per la preparazione di ibodutant (men15596) e relativi intermedi |
ITRM20120331A1 (it) * | 2012-07-12 | 2014-01-13 | Guidotti & C Spa Labor | Composizioni pediatriche orali liquide contenenti nepadutant. |
US20160051596A1 (en) * | 2014-08-21 | 2016-02-25 | Food Industry Research And Development Institute | Novel acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase |
US9867857B2 (en) | 2014-08-21 | 2018-01-16 | Food Industry Research And Development Institute | Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0219318A (ja) * | 1988-06-30 | 1990-01-23 | Carl R Thornfeldt | 疝痛及び生歯に対する治療 |
IT1277835B1 (it) * | 1995-03-13 | 1997-11-12 | Menarini Farma Ind | Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche |
IT1307809B1 (it) * | 1999-10-21 | 2001-11-19 | Menarini Ricerche Spa | Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono. |
MY130373A (en) * | 2001-10-29 | 2007-06-29 | Malesci Sas | Linear basic compounds having nk-2 antagonist activity and formulations thereof |
GB0224788D0 (en) | 2002-10-24 | 2002-12-04 | Novartis Ag | Organic compounds |
-
2004
- 2004-10-27 IT IT000221A patent/ITFI20040221A1/it unknown
-
2005
- 2005-10-24 AR ARP050104429A patent/AR051595A1/es unknown
- 2005-10-26 PL PL05810894T patent/PL1809267T3/pl unknown
- 2005-10-26 RS RSP-2009/0169A patent/RS50780B/sr unknown
- 2005-10-26 CN CNA2005800370703A patent/CN101052386A/zh active Pending
- 2005-10-26 EP EP05810894A patent/EP1809267B1/en active Active
- 2005-10-26 ES ES05810894T patent/ES2325413T3/es active Active
- 2005-10-26 EA EA200700949A patent/EA012264B1/ru not_active IP Right Cessation
- 2005-10-26 US US11/666,204 patent/US7727955B2/en not_active Expired - Fee Related
- 2005-10-26 PT PT05810894T patent/PT1809267E/pt unknown
- 2005-10-26 UA UAA200705837A patent/UA91988C2/ru unknown
- 2005-10-26 SI SI200530661T patent/SI1809267T1/sl unknown
- 2005-10-26 CA CA2584481A patent/CA2584481C/en not_active Expired - Fee Related
- 2005-10-26 DE DE602005012857T patent/DE602005012857D1/de active Active
- 2005-10-26 JP JP2007538414A patent/JP2008517977A/ja active Pending
- 2005-10-26 NZ NZ555380A patent/NZ555380A/en not_active IP Right Cessation
- 2005-10-26 AT AT05810894T patent/ATE422881T1/de active
- 2005-10-26 WO PCT/EP2005/055575 patent/WO2006045820A1/en active Application Filing
- 2005-10-26 DK DK05810894T patent/DK1809267T3/da active
- 2005-10-26 MX MX2007004461A patent/MX2007004461A/es active IP Right Grant
- 2005-10-26 AU AU2005298629A patent/AU2005298629B2/en not_active Ceased
-
2007
- 2007-05-15 ZA ZA200703909A patent/ZA200703909B/xx unknown
- 2007-05-29 NO NO20072720A patent/NO338586B1/no not_active IP Right Cessation
-
2008
- 2008-01-02 HK HK08100016.2A patent/HK1109335A1/xx not_active IP Right Cessation
-
2009
- 2009-04-17 HR HR20090225T patent/HRP20090225T1/xx unknown
- 2009-05-07 CY CY20091100493T patent/CY1109803T1/el unknown
-
2010
- 2010-04-19 US US12/799,176 patent/US20100234284A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7727955B2 (en) | 2010-06-01 |
CA2584481A1 (en) | 2006-05-04 |
US20100234284A1 (en) | 2010-09-16 |
SI1809267T1 (sl) | 2009-06-30 |
WO2006045820A1 (en) | 2006-05-04 |
EP1809267A1 (en) | 2007-07-25 |
CN101052386A (zh) | 2007-10-10 |
US20080090795A1 (en) | 2008-04-17 |
CY1109803T1 (el) | 2014-09-10 |
NO20072720L (no) | 2007-07-09 |
ITFI20040221A1 (it) | 2005-01-27 |
CA2584481C (en) | 2014-07-15 |
ES2325413T3 (es) | 2009-09-03 |
DK1809267T3 (da) | 2009-05-18 |
NO338586B1 (no) | 2016-09-12 |
UA91988C2 (ru) | 2010-09-27 |
HK1109335A1 (en) | 2008-06-06 |
AU2005298629A1 (en) | 2006-05-04 |
NZ555380A (en) | 2008-12-24 |
PL1809267T3 (pl) | 2009-07-31 |
AU2005298629B2 (en) | 2011-02-17 |
EP1809267B1 (en) | 2009-02-18 |
EA200700949A1 (ru) | 2007-10-26 |
ZA200703909B (en) | 2008-09-25 |
RS50780B (sr) | 2010-08-31 |
MX2007004461A (es) | 2007-07-11 |
DE602005012857D1 (de) | 2009-04-02 |
JP2008517977A (ja) | 2008-05-29 |
ATE422881T1 (de) | 2009-03-15 |
PT1809267E (pt) | 2009-05-28 |
HRP20090225T1 (en) | 2009-05-31 |
EA012264B1 (ru) | 2009-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR051595A1 (es) | Composiciones farmaceuticas a base de nk2 antagonista para uso pediatrico | |
RU2487127C2 (ru) | Хиральные цис-имидазолины | |
RU2506257C2 (ru) | Замещенные пирролидин-2-карбоксамиды | |
RU2470022C2 (ru) | Оксазолидиновые антибиотики | |
US7015235B2 (en) | Acylated piperidine derivatives as melanocortin-4 receptor agonists | |
US6818658B2 (en) | Acylated piperidine derivatives as melanocortin-4 receptor agonists | |
PE20000166A1 (es) | Compuestos 4-(2-ceto-1-benzilimidazolinil)piperidina como agonistas del receptor orl1 | |
CA2487489A1 (en) | Mitotic kinesin inhibitors | |
RU2437882C2 (ru) | Производные имидазолидинона | |
PE20050020A1 (es) | DERIVADOS 4-(2-OXO-2,3-DIHIDRO-1-H-IMIDAZO[4,5-b]PIRIDIN-1-IL)-N-(2-OXO-AZEPAN-3-IL)PIPERIDINIL-1-CARBOXAMIDA SUSTITUIDOS COMO ANTAGONISTAS DEL RECEPTOR CGRP | |
WO2005113542B1 (en) | N-cyclic sulfonamido inhibitors of gamma secretase | |
RU2000129161A (ru) | Производное 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способ его получения, фармацевтическая композиция, содержащая указанное соединение, и промежуточный продукт | |
HRP20110640T1 (hr) | Derivati cikličkih amida i njihova proizvodnja te njihova uporaba kao antitromboznih sredstava | |
AU2002255597A1 (en) | Acylated piperidine derivatives as melanocortin-4 receptor agonists | |
CA2682329A1 (en) | Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists | |
PE20060598A1 (es) | Derivado heterociclo conteniendo nitrogeno como antagonista de quimiocina ccr5 | |
CA2575003A1 (en) | Potassium channel inhibitors | |
CN1523986A (zh) | 用于联合治疗的取代的噁唑烷酮类化合物 | |
RU2008120619A (ru) | (гетеро)арилы, обладающие антагонистической активностью по отношению к меланинконцентрирующему гормону | |
RU2003107016A (ru) | Замещенные пиразолы | |
EP1581517B1 (en) | Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists | |
RU2010108687A (ru) | Ариловые эфиры пирролидина в качестве антагонистов рецепторов nk3 | |
PE20070355A1 (es) | Antagonistas de cgrp seleccionados y procedimientos para su preparacion | |
PE20050470A1 (es) | 5-arilpirimidinas como agentes anticancerigenos | |
JP2016514709A5 (es) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |